Cargando…
Comparative serum proteomic analysis identified afamin as a downregulated protein in papillary thyroid carcinoma patients with non-(131)I-avid lung metastases
BACKGROUND: The loss of (131)I uptake ability in metastases from differentiated thyroid carcinoma (DTC) is becoming a major obstacle in radioiodine treatment. However, there is no effective way to screen for (131)I uptake ability in metastases. The identification of differentially expressed proteins...
Autores principales: | Song*, Hong-Jun, Xue*, Yan-Li, Qiu, Zhong-Ling, Luo, Quan-Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3815116/ https://www.ncbi.nlm.nih.gov/pubmed/24089082 http://dx.doi.org/10.1097/MNM.0000000000000001 |
Ejemplares similares
-
AN UNUSUAL CASE OF PAPILLARY THYROID CARCINOMA IODINE-131 AVID METASTASIS TO THE ADRENAL GLAND
por: Blažeković, Ivan, et al.
Publicado: (2018) -
Renal Metastasis and Dual ((18)F-Fluorodeoxyglucose and (131)I) Avid Skeletal Metastasis in a Patient with Papillary Thyroid Cancer
por: Kulkarni, Prashanth, et al.
Publicado: (2017) -
I-131 Avid Tumor Thrombus in a Case of Poorly Differentiated Thyroid Cancer
por: Gill, Sana Munir, et al.
Publicado: (2023) -
Afamin: an early predictor of preeclampsia
por: Köninger, Angela, et al.
Publicado: (2018) -
Serum concentrations of afamin are elevated in patients with polycystic ovary syndrome
por: Köninger, Angela, et al.
Publicado: (2014)